Cargando…
Specificity of oligonucleotide gene therapy (OGT) agents
Oligonucleotide gene therapy (OGT) agents (e. g. antisense, deoxyribozymes, siRNA and CRISPR/Cas) are promising therapeutic tools. Despite extensive efforts, only few OGT drugs have been approved for clinical use. Besides the problem of efficient delivery to targeted cells, hybridization specificity...
Autores principales: | Nedorezova, Daria D., Dubovichenko, Mikhail V., Belyaeva, Ekaterina P., Grigorieva, Ekaterina D., Peresadina, Arina V., Kolpashchikov, Dmitry M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576606/ https://www.ncbi.nlm.nih.gov/pubmed/36276652 http://dx.doi.org/10.7150/thno.77830 |
Ejemplares similares
-
OGT Protein Interaction Network (OGT-PIN): A Curated Database of Experimentally Identified Interaction Proteins of OGT
por: Ma, Junfeng, et al.
Publicado: (2021) -
Visual Detection of Stem-Loop Primer Amplification (SPA) Products without Denaturation Using Peroxidase-like DNA Machines (PxDM)
por: Maltzeva, Yulia I., et al.
Publicado: (2023) -
OGT Ohio graduation test mathematics
por: Brice, J, et al.
Publicado: (2012) -
Towards sustainable diagnostics: replacing unstable H(2)O(2) by photoactive TiO(2) in testing systems for visible and tangible diagnostics for use by blind people
por: Lanchuk, Yulia V., et al.
Publicado: (2018) -
OGT restrains the expansion of DNA damage signaling
por: Chen, Qiang, et al.
Publicado: (2016)